BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11023789)

  • 1. Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP.
    De Guzman RN; Liu HY; Martinez-Yamout M; Dyson HJ; Wright PE
    J Mol Biol; 2000 Oct; 303(2):243-53. PubMed ID: 11023789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response.
    Dames SA; Martinez-Yamout M; De Guzman RN; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5271-6. PubMed ID: 11959977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
    Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
    J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
    Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the transactivation domain of B-Myb with the TAZ2 domain of the coactivator p300: molecular features and properties of the complex.
    Oka O; Waters LC; Strong SL; Dosanjh NS; Veverka V; Muskett FW; Renshaw PS; Klempnauer KH; Carr MD
    PLoS One; 2012; 7(12):e52906. PubMed ID: 23300815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into interactions of C/EBP transcriptional activators with the Taz2 domain of p300.
    Bhaumik P; Davis J; Tropea JE; Cherry S; Johnson PF; Miller M
    Acta Crystallogr D Biol Crystallogr; 2014 Jul; 70(Pt 7):1914-21. PubMed ID: 25004968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional analysis of the DEAF-1 and BS69 MYND domains.
    Kateb F; Perrin H; Tripsianes K; Zou P; Spadaccini R; Bottomley M; Franzmann TM; Buchner J; Ansieau S; Sattler M
    PLoS One; 2013; 8(1):e54715. PubMed ID: 23372760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR chemical shift and relaxation measurements provide evidence for the coupled folding and binding of the p53 transactivation domain.
    Vise PD; Baral B; Latos AJ; Daughdrill GW
    Nucleic Acids Res; 2005; 33(7):2061-77. PubMed ID: 15824059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for antibiotic recognition by the TipA class of multidrug-resistance transcriptional regulators.
    Kahmann JD; Sass HJ; Allan MG; Seto H; Thompson CJ; Grzesiek S
    EMBO J; 2003 Apr; 22(8):1824-34. PubMed ID: 12682015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation domain of Adenovirus Early Region 1A (E1A): Investigating folding dynamics and aggregation.
    Sharma N; Gadhave K; Kumar P; Giri R
    Curr Res Struct Biol; 2022; 4():29-40. PubMed ID: 35146445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of the zinc finger HIT domain in protein FON.
    He F; Umehara T; Tsuda K; Inoue M; Kigawa T; Matsuda T; Yabuki T; Aoki M; Seki E; Terada T; Shirouzu M; Tanaka A; Sugano S; Muto Y; Yokoyama S
    Protein Sci; 2007 Aug; 16(8):1577-87. PubMed ID: 17656577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NMR structure of the murine DLC2 SAM domain reveals a variant fold that is similar to a four-helix bundle.
    Kwan JJ; Donaldson LW
    BMC Struct Biol; 2007 May; 7():34. PubMed ID: 17519008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic neural inducing factor churchill is not a DNA-binding zinc finger protein: solution structure reveals a solvent-exposed beta-sheet and zinc binuclear cluster.
    Lee BM; Buck-Koehntop BA; Martinez-Yamout MA; Dyson HJ; Wright PE
    J Mol Biol; 2007 Aug; 371(5):1274-89. PubMed ID: 17610897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain.
    Wells M; Tidow H; Rutherford TJ; Markwick P; Jensen MR; Mylonas E; Svergun DI; Blackledge M; Fersht AR
    Proc Natl Acad Sci U S A; 2008 Apr; 105(15):5762-7. PubMed ID: 18391200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menke-Hennekam syndrome; delineation of domain-specific subtypes with distinct clinical and DNA methylation profiles.
    Haghshenas S; Bout HJ; Schijns JM; Levy MA; Kerkhof J; Bhai P; McConkey H; Jenkins ZA; Williams EM; Halliday BJ; Huisman SA; Lauffer P; de Waard V; Witteveen L; Banka S; Brady AF; Galazzi E; van Gils J; Hurst ACE; Kaiser FJ; Lacombe D; Martinez-Monseny AF; Fergelot P; Monteiro FP; Parenti I; Persani L; Santos-Simarro F; Simpson BN; ; Alders M; Robertson SP; Sadikovic B; Menke LA
    HGG Adv; 2024 Mar; 5(3):100287. PubMed ID: 38553851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wide-line NMR and DSC studies on intrinsically disordered p53 transactivation domain and its helically pre-structured segment.
    Tompa P; Han KH; Bokor M; Kamasa P; Tantos Á; Fritz B; Kim DH; Lee C; Verebélyi T; Tompa K
    BMB Rep; 2016 Sep; 49(9):497-501. PubMed ID: 27418282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear Magnetic Resonance Solution Structure of the Recombinant Fragment Containing Three Fibrin-Binding Cysteine-Rich Domains of the Very Low Density Lipoprotein Receptor.
    Banerjee K; Yakovlev S; Gruschus JM; Medved L; Tjandra N
    Biochemistry; 2018 Jul; 57(30):4395-4403. PubMed ID: 29965730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical characterization reveals structural disorder in the developmental transcriptional regulator LBH.
    Al-Ali H; Rieger ME; Seldeen KL; Harris TK; Farooq A; Briegel KJ
    Biochem Biophys Res Commun; 2010 Jan; 391(1):1104-9. PubMed ID: 20005203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The winged helix domain of MORF binds CpG islands and the TAZ2 domain of p300.
    Becht DC; Kanai A; Biswas S; Halawa M; Zeng L; Cox KL; Poirier MG; Zhou MM; Shi X; Yokoyama A; Kutateladze TG
    iScience; 2024 Apr; 27(4):109367. PubMed ID: 38500836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the Taz2 domain of p300: insights into ligand binding.
    Miller M; Dauter Z; Cherry S; Tropea JE; Wlodawer A
    Acta Crystallogr D Biol Crystallogr; 2009 Dec; 65(Pt 12):1301-8. PubMed ID: 19966416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.